Powered by

-GENFIT announces plans to conduct registered Public Offering in the United States

Nov 20, 2018 - ENP Newswire

Lille - GENFIT SA (Euronext: GNFT), a French biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, in particular those of metabolic origin, and hepatobiliary diseases, today announced that it plans to conduct a registered public offering of its ordinary shares, in the form of American Depositary Shares ('ADSs'), in the United States and has confidentially submitted a draft registration statement on Form F-1 to the U.S. ...